Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.85 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | PGD | P52209 | 1/20 | 0.37 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30003734 | 1.00 | PDE4A (0.85) | PDE4ALMNAUSP2SLCO1B1TSHR | |
| SCHEMBL16609882 | 1.00 | PDE4A (0.85) | PDE4ALMNAUSP2SLCO1B1TSHR | |
| SCHEMBL15457624 | 1.00 | PDE4A (0.85) | PDE4ALMNAUSP2SLCO1B1TSHR | |
| SCHEMBL13219455 | 1.00 | PDE4A (0.85) | PDE4ALMNAUSP2SLCO1B1TSHR | |
| SCHEMBL12395079 | 1.00 | PDE4A (0.85) | PDE4ALMNAUSP2SLCO1B1TSHR | |
| SCHEMBL15186907 | 1.00 | PDE4A (0.85) | PDE4ALMNAUSP2SLCO1B1TSHR | |
| SCHEMBL416686 | 1.00 | PDE4A (0.85) | PDE4ALMNAUSP2SLCO1B1TSHR | |
| SCHEMBL5238369 | 1.00 | PDE4A (0.85) | PDE4ALMNAUSP2SLCO1B1TSHR | |
| SCHEMBL16609879 | 1.00 | PDE4A (0.85) | PDE4ALMNAUSP2SLCO1B1TSHR | |
| SCHEMBL338307 | 1.00 | PDE4A (0.85) | PDE4ALMNAUSP2SLCO1B1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630578-B2 | Methods for the production of calcium, magnesium, and zinc salts of sugar acids | DFI USA, LLC (US) | 2026-05-19 | — | — | US | claimed |
| EP-3823067-B1 | ORGANIC EXPANDER FOR LEAD STORAGE BATTERY | JUJO PAPER CO LTD (JP) | 2026-02-25 | — | — | EP | claimed |
| US-20260028524-A1 | BLEND OF PHOSPHONATE ACIDS FOR SCALE PREVENTION IN HIGH ALKALINITY AND HIGH CO2 ENVIRONMENTS | HALLIBURTON ENERGY SERVICES, INC (US) | 2026-01-29 | — | — | US | claimed |
| WO-2025263641-A1 | COMPOSITION COMPRISING GLYCOLIPID, CATIONIC POLYMER AND (POLY)HYDROXY ACID | L'OREAL (FR) | 2025-12-26 | — | — | WO | claimed |
| US-20250369123-A1 | ALKOXYIMIDAZOLINIUM QUATERNARY SALT COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS TO INHIBIT CORROSION | ECOLAB USA INC. (US) | 2025-12-04 | — | — | US | claimed |
| US-20250369124-A1 | IMIDAZOLINE-SUGAR CONJUGATE COMPOSITIONS AND METHODS FOR INHIBITING CORROSION | ECOLAB USA INC. (US) | 2025-12-04 | — | — | US | claimed |
| US-20250340912-A1 | METHOD FOR PRODUCING 2,4-DIHYDROXY BUTYRATE OR L-THREONINE USING A MICROBIAL METABOLIC PATHWAY | Technische Universität Dresden (DE) | 2025-11-06 | — | — | US | claimed |
| EP-4629846-A1 | POWDERY SUPPORTED MCT-COMPOSITIONS AND THEIR USE | IOI Oleo GmbH (DE) | 2025-10-15 | — | — | EP | claimed |
| EP-4615986-A1 | BIOCATALYTIC PREPARATION OF POLYOLS DERIVED FROM PENTOSE | Cascat GmbH (DE) | 2025-09-17 | — | — | EP | claimed |
| US-20250281668-A1 | BIOLOGICAL POLYSACCHARIDE HYDROGEL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | QINGDAO HEALTH OCEAN BIOPHARMACEUTICAL CO., LTD. (CN) | 2025-09-11 | — | — | US | claimed |
| US-5177192-A | Radioisotopes; antitumor agents | CENTOCOR, INCORPORATED (US) | 1993-01-05 | — | — | US | claimed |
| US-5120839-A | AMIDO-LINKED OLIGOSACCHARIDE ALDITOLS AND A PROCESS FOR THEIR MANUFACTURE | SUDDEUTSCHE ZUCKER-AKTIENGESELLSCHAFT (DE) | 1992-06-09 | — | — | US | claimed |
| US-5053493-A | Transfering a radioactive metal from a polyhydroxycarboxylic acid complex to a sulfuryl-containing antibody; radioimmunodiagnosis; antitumor and -carcinogenic agents | CENTOCOR CARDIOVASCULAR IMAGING PARTNERS, L.P. (US) | 1991-10-01 | — | — | US | claimed |
| EP-0354923-A1 | METHOD FOR LABELLING ANTIBODIES WITH A METAL ION. | CENTOCOR CARDIOVASCULAR IMAGIN (US) | 1990-02-21 | — | — | EP | claimed |
| WO-1988007382-A2 | METHOD FOR LABELLING ANTIBODIES WITH A METAL ION | CENTOCOR CARDIOVASCULAR IMAGING PARTNERS, L.P. (US) | 1988-10-06 | — | — | WO | claimed |
| EP-0114954-B1 | DERIVATIVES AND REDUCTION PRODUCTS OF D-GLUCOPYRANOSYL-ALPHA(1-5)-D-ARBONIC ACID, THEIR PREPARATION AND USE | Süddeutsche Zucker-Aktiengesellschaft (DE) | 1986-02-19 | — | — | EP | claimed |
| US-4306979-A | Foam type fire extinguishing agent for hydrophilic combustible liquids | HOCHIKI CORPORATION (JP) | 1981-12-22 | — | — | US | claimed |
| US-4125559-A | OXIDATION OF HEXOSES | BASF AKTIENGESELLSCHAFT (DE) | 1978-11-14 | — | — | US | claimed |
| US-3969395-A | WATER SWELLABLE, STABILIZER FOR THERAPUTIC IRON PREPARATIONS | ASTRA LAKEMEDEL AKTIEBOLAG (SW) | 1976-07-13 | — | — | US | claimed |
| US-3965133-A | IRON COMPLEX, TREATMENT FOR IRON DEFICIENCY, INTRAMUSCULAR INJECTION | ASTRA LAKEMEDEL AKTIEBOLAG (SW) | 1976-06-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630578-B2 | Methods for the production of calcium, magnesium, and zinc salts of sugar acids | SLC5A6, SOD1, MGAM | PDE4A 3246/4885LMNA 4496/4885USP2 3179/4885 |
| US-20260028524-A1 | BLEND OF PHOSPHONATE ACIDS FOR SCALE PREVENTION IN HIGH ALKALINITY AND HIGH CO2 ENVIRONMENTS | PHOSPHO1, WEE1, PEBP1 | PDE4A 2939/4885LMNA 1990/4885USP2 4231/4885 |
| US-20250369124-A1 | IMIDAZOLINE-SUGAR CONJUGATE COMPOSITIONS AND METHODS FOR INHIBITING CORROSION | SI, FUT5, MGAM | PDE4A 2799/4885LMNA 3669/4885USP2 3044/4885 |
| US-20250369123-A1 | ALKOXYIMIDAZOLINIUM QUATERNARY SALT COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS TO INHIBIT CORROSION | TFPI, F12, TFPI2 | PDE4A 4044/4885LMNA 2793/4885USP2 3574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.